L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity

J. Soar*, G. Hewson, G. E. Leighton, R. G. Hill, J. Hughes

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

20 Citations (Scopus)


To determine the role of CCK-A receptors in the cholecystokinin (CCK)-induced suppression of locomotor activity in the rat, the ability of the selective CCK-A receptor antagonist L364,718 to block these responses was investigated. Cholecystokinin octapeptide (CCK8) (10,100 μg/kg IP) and caerulein (1, 5, 10 μg/kg IP) produced marked reductions in locomotor activity whereas cholecystokinin tetrapeptide (CCK4) (100 μg/kg IP) was without effect. The reductions in activity produced by CCK8 (10 μg/kg) and caerulein (10 μg/kg) were antagonized by L364,718 (100 μg/kg IP). In an open field test CCK8 (10 μg/kg IP) reduced locomotor activity and total number of rears and increased pause duration. These effects of CCK8 on open-field behaviour were also antagonized by L364,718 (100 μg/kg IP). It is concluded that L364,718 is a potent antagonist of the actions of CCK8 and caerulein on locomotor activity, suggesting that the effects of these peptides are mediated by a CCK-A receptor.

Original languageEnglish
Pages (from-to)637-640
Number of pages4
JournalPharmacology, Biochemistry and Behavior
Issue number3
Publication statusPublished - Jul 1989

Bibliographical note

Copyright 2014 Elsevier B.V., All rights reserved.


  • Cholecystokinin
  • L364,718
  • Locomotor activity


Dive into the research topics of 'L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity'. Together they form a unique fingerprint.

Cite this